A detailed history of Corrado Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Corrado Advisors, LLC holds 32,725 shares of BMY stock, worth $1.88 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
32,725
Previous 33,136 1.24%
Holding current value
$1.88 Million
Previous $1.38 Million 23.04%
% of portfolio
1.28%
Previous 1.06%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$39.66 - $51.75 $16,300 - $21,269
-411 Reduced 1.24%
32,725 $1.69 Million
Q2 2024

Aug 05, 2024

SELL
$40.25 - $52.99 $52,526 - $69,151
-1,305 Reduced 3.79%
33,136 $1.38 Million
Q1 2024

May 09, 2024

SELL
$47.98 - $54.4 $42,750 - $48,470
-891 Reduced 2.52%
34,441 $1.87 Million
Q4 2023

Feb 01, 2024

SELL
$48.48 - $57.85 $63,799 - $76,130
-1,316 Reduced 3.59%
35,332 $1.81 Million
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $41,101 - $45,958
710 Added 1.98%
36,648 $2.13 Million
Q2 2023

Aug 10, 2023

SELL
$63.71 - $70.74 $11,786 - $13,086
-185 Reduced 0.51%
35,938 $2.3 Million
Q1 2023

May 03, 2023

BUY
$65.71 - $74.53 $68,075 - $77,213
1,036 Added 2.95%
36,123 $2.5 Million
Q4 2022

Feb 09, 2023

BUY
$68.48 - $81.09 $38,417 - $45,491
561 Added 1.62%
35,087 $2.52 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $57 - $34,193
-445 Reduced 1.27%
34,526 $2.45 Million
Q2 2022

Aug 10, 2022

BUY
$72.62 - $79.98 $3,848 - $4,238
53 Added 0.15%
34,971 $2.69 Million
Q1 2022

May 05, 2022

BUY
$61.48 - $73.72 $41,806 - $50,129
680 Added 1.99%
34,918 $2.55 Million
Q4 2021

Jan 14, 2022

BUY
$53.63 - $62.52 $33,733 - $39,325
629 Added 1.87%
34,238 $2.14 Million
Q3 2021

Oct 13, 2021

BUY
$59.17 - $69.31 $17,632 - $20,654
298 Added 0.89%
33,609 $1.99 Million
Q2 2021

Jul 20, 2021

BUY
$61.91 - $67.42 $183,872 - $200,237
2,970 Added 9.79%
33,311 $2.23 Million
Q1 2021

Apr 15, 2021

SELL
$59.34 - $66.74 $43,911 - $49,387
-740 Reduced 2.38%
30,341 $1.92 Million
Q4 2020

Jan 28, 2021

SELL
$57.74 - $65.43 $131,012 - $148,460
-2,269 Reduced 6.8%
31,081 $1.93 Million
Q3 2020

Oct 07, 2020

SELL
$57.43 - $63.64 $23,661 - $26,219
-412 Reduced 1.22%
33,350 $2.01 Million
Q2 2020

Jul 07, 2020

SELL
$54.82 - $64.09 $399,089 - $466,575
-7,280 Reduced 17.74%
33,762 $1.99 Million
Q1 2020

Apr 06, 2020

SELL
$46.4 - $67.43 $641,944 - $932,894
-13,835 Reduced 25.21%
41,042 $2.29 Million
Q4 2019

Jan 15, 2020

SELL
$49.21 - $64.19 $191,426 - $249,699
-3,890 Reduced 6.62%
54,877 $3.52 Million
Q3 2019

Oct 08, 2019

SELL
$42.77 - $50.71 $32,291 - $38,286
-755 Reduced 1.27%
58,767 $2.98 Million
Q2 2019

Jul 10, 2019

BUY
$44.62 - $49.34 $1.28 Million - $1.42 Million
28,726 Added 93.28%
59,522 $2.7 Million
Q1 2019

Apr 03, 2019

BUY
$45.12 - $53.8 $1.39 Million - $1.66 Million
30,796 New
30,796 $1.47 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Corrado Advisors, LLC Portfolio

Follow Corrado Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Corrado Advisors, LLC with notifications on news.